MSLP : Summary for MUSCLE PHARM CORP COM USD0.001 - Yahoo Finance

U.S. Markets closed

MusclePharm Corporation (MSLP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.00-0.05 (-2.44%)
At close: 11:52AM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2.05
Bid0.00 x
Ask0.00 x
Day's Range2.00 - 2.08
52 Week Range1.29 - 3.20
Avg. Volume11,714
Market Cap27.67M
PE Ratio (TTM)-1.27
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 months ago

    MusclePharm Announces Hiring Of New Chief Financial Officer

    DENVER, Dec. 2, 2016 /PRNewswire/ -- MusclePharm Corporation (MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition company, today announced the appointment of Peter C. Lynch CPA as the Company's new Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer. Mr. Lynch has a diversified financial background spanning over 25 years, with financial leadership positions at several large corporations that include Kärcher North America, Inc., Honeywell International Inc. and Gates Corp.  Ryan Drexler, MusclePharm's President and Chief Executive Officer, and Chairman of the Board of Directors, said: "We are excited to have Peter join the organization and believe that his proven financial skills will be instrumental in assisting the Company in its continuing efforts to return to profitability and value creation.

  • PR Newswire2 months ago

    Wynnefield Commends Leadership Of MusclePharm CEO

    NEW YORK, Nov. 22, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), stockholders of MusclePharm Corp. (OTCQB: MSLP) ("MusclePharm" or the "Company") ...

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
    Capital Cube2 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016

    Categories: Yahoo Finance Get free summary analysis MusclePharm Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of MusclePharm Corp. – Natural Alternatives International, Inc., GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (NAII-US, GNC-US, MYL-US and BMY-US) that have also reported for this ... Read more (Read more...)